Cover Image
市場調查報告書

中國的血液學市場預測

China Haematology Market Outlook to 2021

出版商 GlobalData 商品編碼 346056
出版日期 內容資訊 英文 47 Pages
訂單完成後即時交付
價格
Back to Top
中國的血液學市場預測 China Haematology Market Outlook to 2021
出版日期: 2015年08月14日 內容資訊: 英文 47 Pages
簡介

本報告提供中國的血液學市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 中國的血液學市場

  • 收益實際成果
  • 收益預測
    • 各市場區隔
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 中國的主要企業概要:血液學市場

  • 企業概要
    • Sysmex Corporation
    • Siemens Healthcare
    • Mindray Medical International Limited
    • 日本光電工業
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • 堀場製作所
    • bioMerieux S.A.
    • Abbott Laboratories

第5章 血液學市場開發中產品

第6章 財務交易形勢

  • 夥伴關係

第7章 最近的發展

  • 公佈財報

第8章 附錄

圖表

目錄
Product Code: GDMECC1245DB

GlobalData's new report, "China Haematology Market Outlook to 2021", provides key market data on the China Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Haematology market.
  • Global corporate-level profiles of key companies operating within the China Haematology market.
  • Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Haematology Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Haematology Market, China

  • 3.1. Haematology Market, China, Revenue ($m), 2007-2014
  • 3.2. Haematology Market, China, Revenue ($m), 2014-2021
    • 3.2.1. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.5. Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.6. Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.7. Haematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.8. Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.9. Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.10. Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021
  • 3.3. Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.4. Haematology Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Haematology Market

  • 4.1. Sysmex Corporation
    • 4.1.1. Company Overview
  • 4.2. Siemens Healthcare
    • 4.2.1. Company Overview
  • 4.3. Mindray Medical International Limited
    • 4.3.1. Company Overview
  • 4.4. Nihon Kohden Corporation
    • 4.4.1. Company Overview
  • 4.5. Danaher Corporation
    • 4.5.1. Company Overview
  • 4.6. F. Hoffmann-La Roche Ltd.
    • 4.6.1. Company Overview
  • 4.7. Horiba, Ltd.
    • 4.7.1. Company Overview
  • 4.8. bioMerieux S.A.
    • 4.8.1. Company Overview
  • 4.9. Abbott Laboratories
    • 4.9.1. Company Overview

5. Haematology Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. NoemaLife Enters into Distribution Agreement with Horiba Medical

7. Recent Developments

  • 7.1. Financial Announcements
    • 7.1.1. Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Company Share Analysis
    • 8.1.5. Distribution Share Analysis
  • 8.2. GlobalData Consulting
  • 8.3. Contact Us
  • 8.4. Disclaimer

List of Tables

  • Table 1: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 8: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 12: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 14: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 15: Haematology Market Pipeline Products
  • Table 16: NoemaLife Enters into Distribution Agreement with Horiba Medical

List of Figures

  • Figure 1: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 8: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Haematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Haematology Market, China, Company Share (%) 2014
Back to Top